Comera Life Sciences (CMRA) Insider Trading & Ownership Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsInsider TradesSEC FilingsTrendsBuy This Stock Comera Life Sciences (NASDAQ:CMRA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage8.90%Number OfInsiders Buying(Last 3 Years)6Amount OfInsider Buying(Last 3 Years)$1.81 MNumber OfInsiders Selling(Last 3 Years)0 Get CMRA Insider Trade Alerts Want to know when executives and insiders are buying or selling Comera Life Sciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CMRA Insider Buying and Selling by Quarter Comera Life Sciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/11/2023Charles CheringtonMajor ShareholderBuy2,053,789$0.51$1,047,432.39 8/14/2023Robert Patrick MahoneyInsiderBuy20,000$0.63$12,600.00 7/31/2023David SoaneMajor ShareholderBuy273,838$0.51$139,657.38 1/4/2023David SoaneMajor ShareholderBuy202,701$1.23$249,322.23 11/8/2022David SoaneMajor ShareholderBuy3,000$1.38$4,140.00 10/20/2022Charles CheringtonMajor ShareholderBuy3,316$1.52$5,040.32 10/17/2022Charles CheringtonMajor ShareholderBuy15,266$1.66$25,341.56 10/13/2022Charles CheringtonMajor ShareholderBuy10,481$1.66$17,398.46 9/29/2022Charles CheringtonMajor ShareholderBuy17,900$1.87$33,473.00 9/27/2022Charles CheringtonMajor ShareholderBuy12,000$1.69$20,280.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 9/12/2022James SherblomDirectorBuy50,000$2.03$101,500.00 9/9/2022Jeffrey S HackmanInsiderBuy47,600$2.06$98,056.00 9/8/2022Michael Gerard CampbellCFOBuy25,000$2.07$51,750.00 (Data available from 1/1/2013 forward) CMRA Insider Trading Activity - Frequently Asked Questions Who is on Comera Life Sciences's Insider Roster? The list of insiders at Comera Life Sciences includes Charles Cherington, David Soane, James Sherblom, Jeffrey S Hackman, Michael Gerard Campbell, and Robert Patrick Mahoney. Learn more on insiders at CMRA. What percentage of Comera Life Sciences stock is owned by insiders? 8.90% of Comera Life Sciences stock is owned by insiders. Learn more on CMRA's insider holdings. Which Comera Life Sciences insiders have been buying company stock? The following insiders have purchased CMRA shares in the last 24 months: Charles Cherington ($1,047,432.39), David Soane ($139,657.38), and Robert Patrick Mahoney ($12,600.00). How much insider buying is happening at Comera Life Sciences? Insiders have purchased a total of 2,347,627 CMRA shares in the last 24 months for a total of $1,199,689.77 bought. Comera Life Sciences Key ExecutivesMr. Michael G. Campbell CPA (Age 55)CEO, CFO & Principal Accounting Officer Compensation: $269.11kDr. David Soane Ph.D.Co-Founder & Member of Scientific Advisory BoardMs. Janice Marie McCourt B.S. (Age 62)CLP, M.B.A., R.Ph., Chief Business Officer More Insider Trading Tools from MarketBeat Related Companies EVLO Insider Trading GNCA Insider Trading CALA Insider Trading AMPE Insider Trading EFTR Insider Trading PXMD Insider Trading SMFL Insider Trading BTMDW Insider Trading CLVRW Insider Trading CLVR Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Buying in This Stock Reiterates Analysts Bullish OutlookBeware of BigBear.ai: Insiders Are Selling—Should You?XPO Buying $50 Million of Its Own Stock: Here's Why Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or HoldJoby Aviation: Operational Momentum vs. Market Sentiment This page (NASDAQ:CMRA) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | SponsoredTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump announcement boosts “next Bitcoin”President Trump just made his first big crypto move ... Announcing the creation of a national strategic re...Weiss Ratings | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Comera Life Sciences Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Comera Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.